| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | diacylglycerol binding | 3.13e-04 | 16 | 33 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 7.15e-04 | 24 | 33 | 2 | GO:0017075 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.44e-03 | 34 | 33 | 2 | GO:0030507 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 2.48e-06 | 2 | 33 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.20e-05 | 502 | 33 | 7 | GO:0008380 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 1.49e-05 | 4 | 33 | 2 | GO:0061789 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.83e-05 | 207 | 33 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.18e-05 | 551 | 33 | 7 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 5.19e-05 | 129 | 33 | 4 | GO:0048024 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 1.11e-04 | 10 | 33 | 2 | GO:0099525 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.14e-04 | 158 | 33 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.14e-04 | 59 | 33 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 1.62e-04 | 12 | 33 | 2 | GO:0099011 | |
| GeneOntologyBiologicalProcess | regulation of ribonucleoprotein complex localization | 1.91e-04 | 13 | 33 | 2 | GO:2000197 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle priming | 2.23e-04 | 14 | 33 | 2 | GO:0010807 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 2.23e-04 | 14 | 33 | 2 | GO:0071166 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.44e-04 | 358 | 33 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.44e-04 | 358 | 33 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.57e-04 | 362 | 33 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 2.57e-04 | 15 | 33 | 2 | GO:1990504 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.72e-04 | 79 | 33 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 3.33e-04 | 17 | 33 | 2 | GO:0016081 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 5.20e-04 | 917 | 33 | 7 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of short-term neuronal synaptic plasticity | 5.62e-04 | 22 | 33 | 2 | GO:0048172 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 7.28e-04 | 25 | 33 | 2 | GO:0048791 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 9.14e-04 | 28 | 33 | 2 | GO:0032253 | |
| GeneOntologyBiologicalProcess | myelin assembly | 9.14e-04 | 28 | 33 | 2 | GO:0032288 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.09e-03 | 127 | 33 | 3 | GO:0006368 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 1.12e-03 | 31 | 33 | 2 | GO:0016082 | |
| GeneOntologyBiologicalProcess | heart development | 1.14e-03 | 757 | 33 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.27e-03 | 134 | 33 | 3 | GO:0003279 | |
| GeneOntologyBiologicalProcess | innervation | 1.35e-03 | 34 | 33 | 2 | GO:0060384 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 1.35e-03 | 34 | 33 | 2 | GO:0032252 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 1.38e-03 | 138 | 33 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.50e-03 | 142 | 33 | 3 | GO:0034728 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 1.56e-03 | 144 | 33 | 3 | GO:0006354 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | 1.64e-03 | 546 | 33 | 5 | GO:0051656 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 1.68e-03 | 38 | 33 | 2 | GO:0035987 | |
| GeneOntologyBiologicalProcess | heart growth | 1.69e-03 | 148 | 33 | 3 | GO:0060419 | |
| GeneOntologyCellularComponent | nuclear speck | 5.13e-05 | 431 | 33 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 8.64e-05 | 9 | 33 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 5.99e-04 | 23 | 33 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | neuromuscular junction | 7.27e-04 | 112 | 33 | 3 | GO:0031594 | |
| Domain | Unc-13 | 9.07e-06 | 3 | 33 | 2 | IPR027080 | |
| Domain | Munc13_dom-2 | 3.02e-05 | 5 | 33 | 2 | IPR014772 | |
| Domain | Membr_traf_MHD | 3.02e-05 | 5 | 33 | 2 | PF10540 | |
| Domain | DUF1041 | 3.02e-05 | 5 | 33 | 2 | SM01145 | |
| Domain | MHD2 | 3.02e-05 | 5 | 33 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.02e-05 | 5 | 33 | 2 | IPR019558 | |
| Domain | DUF1041 | 6.32e-05 | 7 | 33 | 2 | PF06292 | |
| Domain | Munc13_1 | 6.32e-05 | 7 | 33 | 2 | IPR014770 | |
| Domain | CAPS_dom | 6.32e-05 | 7 | 33 | 2 | IPR010439 | |
| Domain | MHD1 | 6.32e-05 | 7 | 33 | 2 | PS51258 | |
| Domain | - | 1.35e-04 | 10 | 33 | 2 | 4.10.1060.10 | |
| Domain | RRM_1 | 4.75e-04 | 208 | 33 | 4 | PF00076 | |
| Domain | RRM | 5.57e-04 | 217 | 33 | 4 | SM00360 | |
| Domain | RRM_dom | 6.59e-04 | 227 | 33 | 4 | IPR000504 | |
| Domain | zf-RanBP | 6.84e-04 | 22 | 33 | 2 | PF00641 | |
| Domain | RRM | 6.93e-04 | 230 | 33 | 4 | PS50102 | |
| Domain | G_patch | 7.48e-04 | 23 | 33 | 2 | SM00443 | |
| Domain | G_patch_dom | 7.48e-04 | 23 | 33 | 2 | IPR000467 | |
| Domain | ZnF_RBZ | 7.48e-04 | 23 | 33 | 2 | SM00547 | |
| Domain | G-patch | 7.48e-04 | 23 | 33 | 2 | PF01585 | |
| Domain | G_PATCH | 7.48e-04 | 23 | 33 | 2 | PS50174 | |
| Domain | ZF_RANBP2_2 | 7.48e-04 | 23 | 33 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 8.15e-04 | 24 | 33 | 2 | PS01358 | |
| Domain | - | 8.63e-04 | 244 | 33 | 4 | 3.30.70.330 | |
| Domain | Znf_RanBP2 | 8.85e-04 | 25 | 33 | 2 | IPR001876 | |
| Domain | Nucleotide-bd_a/b_plait | 1.06e-03 | 258 | 33 | 4 | IPR012677 | |
| Domain | C2 | 1.58e-03 | 131 | 33 | 3 | PF00168 | |
| Domain | C2 | 1.79e-03 | 137 | 33 | 3 | SM00239 | |
| Domain | C2 | 1.99e-03 | 142 | 33 | 3 | PS50004 | |
| Domain | - | 2.23e-03 | 148 | 33 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 2.99e-03 | 164 | 33 | 3 | IPR000008 | |
| Domain | C1_1 | 4.55e-03 | 57 | 33 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 5.70e-03 | 64 | 33 | 2 | PS00479 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RBM5 BAZ1B RBM15 CHD1 FASN MYH10 DDX17 LUC7L2 RBM10 DNAJA2 EIF4B SUPT16H | 5.36e-11 | 989 | 33 | 12 | 36424410 |
| Pubmed | RBM5 RBM15 FASN MYH10 DDX17 LUC7L2 RBM10 ZC3H13 DNAJA2 EIF4B | 6.13e-11 | 551 | 33 | 10 | 34728620 | |
| Pubmed | 7.82e-11 | 251 | 33 | 8 | 31076518 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RBM5 BAZ1B RBM15 MYH10 DDX17 LEO1 LUC7L2 RBM10 ZC3H13 SUPT16H | 1.52e-10 | 605 | 33 | 10 | 28977666 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.64e-09 | 774 | 33 | 10 | 15302935 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RBM5 RBM15 DMXL2 SETD2 MYH10 DDX17 LUC7L2 UNC13A RBM10 ZC3H13 SUPT16H | 2.60e-09 | 1082 | 33 | 11 | 38697112 |
| Pubmed | 3.88e-09 | 847 | 33 | 10 | 35850772 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.83e-09 | 934 | 33 | 10 | 33916271 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 1.20e-08 | 169 | 33 | 6 | 23084401 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SENP6 BAZ1B RBM15 SETD2 CHD1 DDX17 RBM10 ZC3H13 EIF4B SUPT16H | 1.20e-08 | 954 | 33 | 10 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RBM5 BAZ1B RBM15 SETD2 DDX17 LEO1 LUC7L2 RBM10 ZC3H13 DNAJA2 SUPT16H | 1.65e-08 | 1294 | 33 | 11 | 30804502 |
| Pubmed | 2.48e-08 | 191 | 33 | 6 | 20195357 | ||
| Pubmed | 6.21e-08 | 383 | 33 | 7 | 29331416 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.35e-07 | 922 | 33 | 9 | 27609421 | |
| Pubmed | 2.01e-07 | 272 | 33 | 6 | 31010829 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | BAZ1B RBM15 CHD1 FASN MYH10 DDX17 CLK2 LUC7L2 ZC3H13 SUPT16H | 2.46e-07 | 1318 | 33 | 10 | 30463901 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.74e-07 | 477 | 33 | 7 | 31300519 | |
| Pubmed | 2.94e-07 | 723 | 33 | 8 | 34133714 | ||
| Pubmed | 3.02e-07 | 1014 | 33 | 9 | 32416067 | ||
| Pubmed | 3.54e-07 | 1371 | 33 | 10 | 36244648 | ||
| Pubmed | 4.04e-07 | 754 | 33 | 8 | 35906200 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 4.54e-07 | 163 | 33 | 5 | 22113938 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 4.92e-07 | 317 | 33 | 6 | 17620599 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RBM5 BAZ1B RBM15 CHD1 FASN MYH10 DDX17 LUC7L2 DNAJA2 SUPT16H | 5.05e-07 | 1425 | 33 | 10 | 30948266 |
| Pubmed | 5.24e-07 | 1431 | 33 | 10 | 37142655 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 6.74e-07 | 807 | 33 | 8 | 22681889 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.53e-07 | 341 | 33 | 6 | 32971831 | |
| Pubmed | 7.97e-07 | 1139 | 33 | 9 | 36417873 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 8.73e-07 | 2 | 33 | 2 | 28426965 | |
| Pubmed | Exon sharing of a novel human zinc-finger gene, ZIM2, and paternally expressed gene 3 (PEG3). | 8.73e-07 | 2 | 33 | 2 | 10708526 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 35613050 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23770256 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 8.73e-07 | 2 | 33 | 2 | 30816091 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12070347 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28662214 | ||
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 8.73e-07 | 2 | 33 | 2 | 19558619 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 12871971 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 18701688 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 17561838 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23070049 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 8.73e-07 | 2 | 33 | 2 | 31851910 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 8.73e-07 | 2 | 33 | 2 | 28489077 | |
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 8.73e-07 | 2 | 33 | 2 | 11832228 | |
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 8.73e-07 | 2 | 33 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 8.73e-07 | 2 | 33 | 2 | 22066784 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 8.73e-07 | 2 | 33 | 2 | 23229896 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 8.73e-07 | 2 | 33 | 2 | 32187536 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 11792326 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 28586478 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 8.73e-07 | 2 | 33 | 2 | 28772123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 8.73e-07 | 2 | 33 | 2 | 17267576 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22814762 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.04e-06 | 582 | 33 | 7 | 20467437 | |
| Pubmed | 1.29e-06 | 601 | 33 | 7 | 33658012 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.80e-06 | 1257 | 33 | 9 | 36526897 | |
| Pubmed | 1.97e-06 | 641 | 33 | 7 | 36057605 | ||
| Pubmed | 2.39e-06 | 660 | 33 | 7 | 32780723 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.51e-06 | 665 | 33 | 7 | 30457570 | |
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 2.62e-06 | 3 | 33 | 2 | 37343100 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17639022 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23658173 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 33105896 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22966208 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26784654 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 15988013 | ||
| Pubmed | 2.68e-06 | 971 | 33 | 8 | 33306668 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 2.85e-06 | 678 | 33 | 7 | 30209976 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.88e-06 | 430 | 33 | 6 | 38172120 | |
| Pubmed | 3.33e-06 | 441 | 33 | 6 | 31239290 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.96e-06 | 1024 | 33 | 8 | 24711643 | |
| Pubmed | 4.67e-06 | 731 | 33 | 7 | 29298432 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 4.74e-06 | 1415 | 33 | 9 | 28515276 | |
| Pubmed | Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo. | 5.23e-06 | 4 | 33 | 2 | 10488064 | |
| Pubmed | Fbxo45, a novel ubiquitin ligase, regulates synaptic activity. | 5.23e-06 | 4 | 33 | 2 | 19996097 | |
| Pubmed | Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing. | 5.23e-06 | 4 | 33 | 2 | 15123597 | |
| Pubmed | ELKS1 localizes the synaptic vesicle priming protein bMunc13-2 to a specific subset of active zones. | 5.23e-06 | 4 | 33 | 2 | 28264913 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 24332178 | ||
| Pubmed | 5.28e-06 | 121 | 33 | 4 | 22412018 | ||
| Pubmed | 5.53e-06 | 1442 | 33 | 9 | 35575683 | ||
| Pubmed | 5.80e-06 | 274 | 33 | 5 | 34244482 | ||
| Pubmed | 6.15e-06 | 491 | 33 | 6 | 36273042 | ||
| Pubmed | 6.60e-06 | 497 | 33 | 6 | 23414517 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.78e-06 | 283 | 33 | 5 | 30585729 | |
| Pubmed | 7.06e-06 | 503 | 33 | 6 | 16964243 | ||
| Pubmed | 7.14e-06 | 286 | 33 | 5 | 32041737 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 22248876 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 8.72e-06 | 5 | 33 | 2 | 34706221 | |
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 8.72e-06 | 5 | 33 | 2 | 33139401 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 29483509 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 34048454 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 32755572 | ||
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 8.72e-06 | 5 | 33 | 2 | 26575293 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 9.21e-06 | 1149 | 33 | 8 | 35446349 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 24100041 | ||
| Pubmed | Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles. | 1.31e-05 | 6 | 33 | 2 | 28635948 | |
| Pubmed | 1.36e-05 | 327 | 33 | 5 | 31409639 | ||
| Pubmed | 1.64e-05 | 340 | 33 | 5 | 29478914 | ||
| Pubmed | 1.67e-05 | 162 | 33 | 4 | 25796446 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.71e-05 | 588 | 33 | 6 | 38580884 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.74e-05 | 344 | 33 | 5 | 30333137 | |
| Interaction | RAD18 interactions | 1.89e-09 | 457 | 33 | 10 | int:RAD18 | |
| Interaction | NUP43 interactions | SENP6 RBM15 SETD2 CHD1 DDX17 LEO1 LUC7L2 ZC3H13 DNAJA2 SUPT16H | 3.72e-08 | 625 | 33 | 10 | int:NUP43 |
| Interaction | DDX23 interactions | 5.31e-08 | 480 | 33 | 9 | int:DDX23 | |
| Interaction | PRMT1 interactions | RBM5 RBM15 FASN MYH10 DDX17 CLK2 LUC7L2 RBM10 ZC3H13 DNAJA2 EIF4B | 1.43e-07 | 929 | 33 | 11 | int:PRMT1 |
| Interaction | NAA40 interactions | SENP6 BAZ1B SETD2 CHD1 FASN MYH10 DDX17 ANK2 RBM10 EIF4B SUPT16H | 2.40e-07 | 978 | 33 | 11 | int:NAA40 |
| Interaction | FGF11 interactions | 3.02e-07 | 170 | 33 | 6 | int:FGF11 | |
| Interaction | DHX8 interactions | 3.86e-07 | 292 | 33 | 7 | int:DHX8 | |
| Interaction | DOT1L interactions | 4.01e-07 | 807 | 33 | 10 | int:DOT1L | |
| Interaction | SNRNP40 interactions | 5.82e-07 | 637 | 33 | 9 | int:SNRNP40 | |
| Interaction | EED interactions | RBM5 BAZ1B RBM15 LSR FASN MYH10 DDX17 CLK2 ZC3H13 PEG3 MAD1L1 SUPT16H | 1.52e-06 | 1445 | 33 | 12 | int:EED |
| Interaction | CENPA interactions | 2.13e-06 | 377 | 33 | 7 | int:CENPA | |
| Interaction | CHD3 interactions | 2.43e-06 | 757 | 33 | 9 | int:CHD3 | |
| Interaction | DHX40 interactions | 2.80e-06 | 249 | 33 | 6 | int:DHX40 | |
| Interaction | SMC5 interactions | SENP6 BAZ1B RBM15 SETD2 CHD1 DDX17 RBM10 ZC3H13 EIF4B SUPT16H | 2.82e-06 | 1000 | 33 | 10 | int:SMC5 |
| Interaction | MECP2 interactions | RBM5 RBM15 DMXL2 SETD2 MYH10 DDX17 LUC7L2 UNC13A RBM10 ZC3H13 SUPT16H | 3.61e-06 | 1287 | 33 | 11 | int:MECP2 |
| Interaction | MEN1 interactions | RBM5 BAZ1B RBM15 CHD1 MYH10 DDX17 RBM10 ZC3H13 MAD1L1 SUPT16H | 3.64e-06 | 1029 | 33 | 10 | int:MEN1 |
| Interaction | UFL1 interactions | RBM15 FASN MYH10 DDX17 LUC7L2 RBM10 DNAJA2 EIF4B SEC62 SUPT16H | 3.70e-06 | 1031 | 33 | 10 | int:UFL1 |
| Interaction | MAGOH interactions | 3.93e-06 | 264 | 33 | 6 | int:MAGOH | |
| Interaction | CBX3 interactions | 7.29e-06 | 646 | 33 | 8 | int:CBX3 | |
| Interaction | ZC3H18 interactions | 8.07e-06 | 877 | 33 | 9 | int:ZC3H18 | |
| Interaction | H3C1 interactions | 1.00e-05 | 901 | 33 | 9 | int:H3C1 | |
| Interaction | SNRPA interactions | 1.07e-05 | 482 | 33 | 7 | int:SNRPA | |
| Interaction | SSRP1 interactions | 1.12e-05 | 685 | 33 | 8 | int:SSRP1 | |
| Interaction | EIF4A3 interactions | 1.34e-05 | 499 | 33 | 7 | int:EIF4A3 | |
| Interaction | CHD4 interactions | 1.38e-05 | 938 | 33 | 9 | int:CHD4 | |
| Interaction | MBD6 interactions | 1.44e-05 | 91 | 33 | 4 | int:MBD6 | |
| Interaction | TNIP2 interactions | 1.56e-05 | 952 | 33 | 9 | int:TNIP2 | |
| Interaction | CSNK2A1 interactions | 1.61e-05 | 956 | 33 | 9 | int:CSNK2A1 | |
| Interaction | PRC1 interactions | 1.85e-05 | 973 | 33 | 9 | int:PRC1 | |
| Interaction | CPSF6 interactions | 1.88e-05 | 526 | 33 | 7 | int:CPSF6 | |
| Interaction | YWHAG interactions | RBM15 LSR MYH10 DDX17 ANKRD55 CLK2 LUC7L2 ZC3H13 EIF4B MAD1L1 | 1.99e-05 | 1248 | 33 | 10 | int:YWHAG |
| Interaction | SNRNP70 interactions | 2.03e-05 | 984 | 33 | 9 | int:SNRNP70 | |
| Interaction | CHST5 interactions | 2.31e-05 | 34 | 33 | 3 | int:CHST5 | |
| Interaction | SNAI1 interactions | 2.39e-05 | 546 | 33 | 7 | int:SNAI1 | |
| Interaction | PTK6 interactions | 2.44e-05 | 104 | 33 | 4 | int:PTK6 | |
| Interaction | DCAF4 interactions | 3.02e-05 | 378 | 33 | 6 | int:DCAF4 | |
| Interaction | UBE2O interactions | 3.12e-05 | 790 | 33 | 8 | int:UBE2O | |
| Interaction | RBM39 interactions | 3.19e-05 | 1042 | 33 | 9 | int:RBM39 | |
| Interaction | SLX4 interactions | 3.22e-05 | 572 | 33 | 7 | int:SLX4 | |
| Interaction | NLE1 interactions | 3.25e-05 | 228 | 33 | 5 | int:NLE1 | |
| Interaction | CAPZB interactions | 3.36e-05 | 1049 | 33 | 9 | int:CAPZB | |
| Interaction | KIF20A interactions | 3.44e-05 | 1052 | 33 | 9 | int:KIF20A | |
| Interaction | KCNK16 interactions | 4.40e-05 | 42 | 33 | 3 | int:KCNK16 | |
| Interaction | YAP1 interactions | 4.71e-05 | 1095 | 33 | 9 | int:YAP1 | |
| Interaction | MTF1 interactions | 4.71e-05 | 123 | 33 | 4 | int:MTF1 | |
| Interaction | CUL7 interactions | 5.04e-05 | 845 | 33 | 8 | int:CUL7 | |
| Interaction | KCTD13 interactions | 5.16e-05 | 1394 | 33 | 10 | int:KCTD13 | |
| Interaction | RBM7 interactions | 5.18e-05 | 126 | 33 | 4 | int:RBM7 | |
| Interaction | NR2C2 interactions | BAZ1B RBM15 CHD1 FASN MYH10 DDX17 CLK2 LUC7L2 ZC3H13 SUPT16H | 5.45e-05 | 1403 | 33 | 10 | int:NR2C2 |
| Interaction | RNF40 interactions | 6.19e-05 | 261 | 33 | 5 | int:RNF40 | |
| Interaction | ATRX interactions | 6.89e-05 | 267 | 33 | 5 | int:ATRX | |
| Interaction | CEBPB interactions | BAZ1B FASN DDX17 LEO1 LUC7L2 RBM10 DNAJA2 EIF4B MAD1L1 SUPT16H | 6.91e-05 | 1443 | 33 | 10 | int:CEBPB |
| Interaction | EFTUD2 interactions | CHD1 FASN MYH10 DDX17 LEO1 ANKRD55 LUC7L2 DNAJA2 EIF4B SUPT16H | 7.16e-05 | 1449 | 33 | 10 | int:EFTUD2 |
| Interaction | CIT interactions | 7.20e-05 | 1450 | 33 | 10 | int:CIT | |
| Interaction | H2BC9 interactions | 7.58e-05 | 446 | 33 | 6 | int:H2BC9 | |
| Interaction | OBSL1 interactions | 7.98e-05 | 902 | 33 | 8 | int:OBSL1 | |
| Interaction | TRIM33 interactions | 8.26e-05 | 453 | 33 | 6 | int:TRIM33 | |
| Interaction | RC3H2 interactions | 8.50e-05 | 667 | 33 | 7 | int:RC3H2 | |
| Interaction | CIC interactions | 8.99e-05 | 673 | 33 | 7 | int:CIC | |
| Interaction | PINK1 interactions | 9.50e-05 | 679 | 33 | 7 | int:PINK1 | |
| Interaction | METTL3 interactions | 9.68e-05 | 287 | 33 | 5 | int:METTL3 | |
| Interaction | NUPR1 interactions | 9.86e-05 | 683 | 33 | 7 | int:NUPR1 | |
| Interaction | CHMP4C interactions | 1.02e-04 | 687 | 33 | 7 | int:CHMP4C | |
| Interaction | SF3A1 interactions | 1.02e-04 | 471 | 33 | 6 | int:SF3A1 | |
| Interaction | TOP1 interactions | 1.11e-04 | 696 | 33 | 7 | int:TOP1 | |
| Interaction | ARRB1 interactions | 1.27e-04 | 304 | 33 | 5 | int:ARRB1 | |
| Interaction | DDRGK1 interactions | 1.30e-04 | 1249 | 33 | 9 | int:DDRGK1 | |
| Interaction | ISG15 interactions | 1.33e-04 | 494 | 33 | 6 | int:ISG15 | |
| Interaction | SRPK2 interactions | 1.33e-04 | 717 | 33 | 7 | int:SRPK2 | |
| Interaction | NDEL1 interactions | 1.44e-04 | 164 | 33 | 4 | int:NDEL1 | |
| Interaction | DHX15 interactions | 1.45e-04 | 502 | 33 | 6 | int:DHX15 | |
| Interaction | SRSF6 interactions | 1.47e-04 | 503 | 33 | 6 | int:SRSF6 | |
| Interaction | GLDC interactions | 1.64e-04 | 321 | 33 | 5 | int:GLDC | |
| Interaction | TWIST1 interactions | 1.65e-04 | 170 | 33 | 4 | int:TWIST1 | |
| Interaction | DNAJC24 interactions | 1.70e-04 | 12 | 33 | 2 | int:DNAJC24 | |
| Interaction | COP1 interactions | 1.76e-04 | 326 | 33 | 5 | int:COP1 | |
| Interaction | BAP1 interactions | 1.91e-04 | 1314 | 33 | 9 | int:BAP1 | |
| Interaction | POLR2A interactions | 2.07e-04 | 536 | 33 | 6 | int:POLR2A | |
| Interaction | SBDS interactions | 2.10e-04 | 181 | 33 | 4 | int:SBDS | |
| Interaction | ATXN1 interactions | 2.13e-04 | 1039 | 33 | 8 | int:ATXN1 | |
| Interaction | PRPF8 interactions | 2.17e-04 | 776 | 33 | 7 | int:PRPF8 | |
| Interaction | SREK1 interactions | 2.19e-04 | 183 | 33 | 4 | int:SREK1 | |
| Interaction | ANO7 interactions | 2.21e-04 | 72 | 33 | 3 | int:ANO7 | |
| Interaction | FBP1 interactions | 2.38e-04 | 348 | 33 | 5 | int:FBP1 | |
| Interaction | CBLL1 interactions | 2.40e-04 | 74 | 33 | 3 | int:CBLL1 | |
| Interaction | COIL interactions | 2.42e-04 | 552 | 33 | 6 | int:COIL | |
| Interaction | METTL14 interactions | 2.57e-04 | 558 | 33 | 6 | int:METTL14 | |
| Interaction | SSTR1 interactions | 2.69e-04 | 15 | 33 | 2 | int:SSTR1 | |
| Interaction | ZRSR2 interactions | 2.69e-04 | 77 | 33 | 3 | int:ZRSR2 | |
| Interaction | MECOM interactions | 2.71e-04 | 358 | 33 | 5 | int:MECOM | |
| Interaction | CLK2 interactions | 2.79e-04 | 195 | 33 | 4 | int:CLK2 | |
| Interaction | DDX39B interactions | 2.88e-04 | 570 | 33 | 6 | int:DDX39B | |
| Interaction | UHRF2 interactions | 3.07e-04 | 200 | 33 | 4 | int:UHRF2 | |
| Interaction | LRRC31 interactions | 3.38e-04 | 205 | 33 | 4 | int:LRRC31 | |
| Interaction | SLFN11 interactions | 3.40e-04 | 376 | 33 | 5 | int:SLFN11 | |
| Interaction | MED1 interactions | 3.44e-04 | 206 | 33 | 4 | int:MED1 | |
| Interaction | SUMO2 interactions | 3.50e-04 | 591 | 33 | 6 | int:SUMO2 | |
| Interaction | YWHAQ interactions | 3.50e-04 | 1118 | 33 | 8 | int:YWHAQ | |
| Interaction | ZFP36L2 interactions | 3.77e-04 | 211 | 33 | 4 | int:ZFP36L2 | |
| Interaction | CDC5L interactions | 3.92e-04 | 855 | 33 | 7 | int:CDC5L | |
| Cytoband | 15q21.2 | 2.01e-04 | 29 | 33 | 2 | 15q21.2 | |
| Cytoband | 19q13.4 | 1.49e-03 | 79 | 33 | 2 | 19q13.4 | |
| GeneFamily | UNC13 homologs | 1.10e-05 | 4 | 25 | 2 | 836 | |
| GeneFamily | RNA binding motif containing | 1.95e-04 | 213 | 25 | 4 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 3.79e-04 | 21 | 25 | 2 | 89 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 4.17e-04 | 22 | 25 | 2 | 579 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 7.54e-06 | 384 | 33 | 6 | M1865 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 9.78e-06 | 402 | 33 | 6 | MM1248 | |
| Coexpression | DANG_BOUND_BY_MYC | 3.95e-05 | 1061 | 33 | 8 | M15774 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.53e-05 | 180 | 33 | 4 | M8239 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 7.86e-05 | 856 | 33 | 7 | M4500 | |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP | 1.01e-04 | 194 | 33 | 4 | M8340 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 1.09e-04 | 198 | 33 | 4 | M8355 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN | 1.11e-04 | 199 | 33 | 4 | M4049 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 1.11e-04 | 199 | 33 | 4 | M6932 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 1.13e-04 | 200 | 33 | 4 | M5055 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.42e-04 | 212 | 33 | 4 | MM3816 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.98e-04 | 90 | 33 | 3 | M39250 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.35e-05 | 1257 | 33 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 2.29e-05 | 379 | 33 | 6 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 2.57e-05 | 387 | 33 | 6 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 4.88e-05 | 1459 | 33 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 1.05e-04 | 159 | 33 | 4 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.26e-04 | 167 | 33 | 4 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.40e-04 | 831 | 33 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.74e-04 | 595 | 33 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.77e-04 | 379 | 33 | 5 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.88e-04 | 382 | 33 | 5 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 2.99e-04 | 84 | 33 | 3 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.05e-04 | 387 | 33 | 5 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 3.68e-04 | 403 | 33 | 5 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 3.94e-04 | 409 | 33 | 5 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_200 | 3.94e-04 | 19 | 33 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.12e-04 | 413 | 33 | 5 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 184 | 33 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 33 | 4 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 195 | 33 | 4 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 198 | 33 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-05 | 200 | 33 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.47e-04 | 139 | 33 | 3 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 1.50e-04 | 140 | 33 | 3 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.52e-04 | 167 | 33 | 3 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 168 | 33 | 3 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 168 | 33 | 3 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 33 | 3 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.09e-04 | 179 | 33 | 3 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-04 | 181 | 33 | 3 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.25e-04 | 182 | 33 | 3 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 185 | 33 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 185 | 33 | 3 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.41e-04 | 185 | 33 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 188 | 33 | 3 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 188 | 33 | 3 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.57e-04 | 188 | 33 | 3 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 188 | 33 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.63e-04 | 189 | 33 | 3 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 191 | 33 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.74e-04 | 191 | 33 | 3 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.80e-04 | 192 | 33 | 3 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 192 | 33 | 3 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 192 | 33 | 3 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 192 | 33 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 192 | 33 | 3 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-04 | 193 | 33 | 3 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 194 | 33 | 3 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-04 | 194 | 33 | 3 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.92e-04 | 194 | 33 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 194 | 33 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 194 | 33 | 3 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 195 | 33 | 3 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.97e-04 | 195 | 33 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 195 | 33 | 3 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-04 | 196 | 33 | 3 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 196 | 33 | 3 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.03e-04 | 196 | 33 | 3 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.03e-04 | 196 | 33 | 3 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-04 | 196 | 33 | 3 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.09e-04 | 197 | 33 | 3 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 4.09e-04 | 197 | 33 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.09e-04 | 197 | 33 | 3 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.09e-04 | 197 | 33 | 3 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-E_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-04 | 198 | 33 | 3 | 498f11441c0a0982738537bcfcfc2877866b7400 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.16e-04 | 198 | 33 | 3 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-04 | 199 | 33 | 3 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.22e-04 | 199 | 33 | 3 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.22e-04 | 199 | 33 | 3 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| Computational | Neighborhood of HDAC1 | 7.91e-05 | 110 | 23 | 4 | GNF2_HDAC1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Neighborhood of DDX5 | 3.13e-04 | 63 | 23 | 3 | GNF2_DDX5 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.64e-06 | 179 | 33 | 5 | 5822_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 7.16e-06 | 188 | 33 | 5 | 345_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 7.35e-06 | 189 | 33 | 5 | 410_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 9.43e-06 | 199 | 33 | 5 | 346_DN | |
| Drug | silicon cation | 2.03e-05 | 5 | 33 | 2 | CID016019983 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.16e-04 | 175 | 33 | 4 | 4072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.21e-04 | 177 | 33 | 4 | 6340_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.21e-04 | 177 | 33 | 4 | 3227_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 178 | 33 | 4 | 4436_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 178 | 33 | 4 | 5086_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.24e-04 | 178 | 33 | 4 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.26e-04 | 179 | 33 | 4 | 5484_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.29e-04 | 180 | 33 | 4 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.35e-04 | 182 | 33 | 4 | 1891_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.38e-04 | 183 | 33 | 4 | 4527_DN | |
| Drug | Spiperone [749-02-0]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.47e-04 | 186 | 33 | 4 | 5777_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.50e-04 | 187 | 33 | 4 | 2669_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 1.50e-04 | 187 | 33 | 4 | 448_DN | |
| Drug | 6-azauracil | 1.55e-04 | 72 | 33 | 3 | CID000068037 | |
| Drug | AC1L1B78 | 1.55e-04 | 72 | 33 | 3 | CID000001313 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.59e-04 | 190 | 33 | 4 | 4307_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.62e-04 | 191 | 33 | 4 | 4303_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.62e-04 | 191 | 33 | 4 | 7503_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.66e-04 | 192 | 33 | 4 | 4274_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.66e-04 | 192 | 33 | 4 | 6808_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 1.66e-04 | 192 | 33 | 4 | 4311_DN | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.66e-04 | 192 | 33 | 4 | 6044_DN | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.69e-04 | 193 | 33 | 4 | 4289_UP | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 5089_DN | |
| Drug | euxanthone | 1.83e-04 | 14 | 33 | 2 | CID005281631 | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 5816_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 3081_DN | |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | 1.90e-04 | 199 | 33 | 4 | 165_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A | 1.90e-04 | 199 | 33 | 4 | 1964_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | 1.94e-04 | 200 | 33 | 4 | 4075_DN | |
| Disease | Neurodevelopmental Disorders | 1.54e-04 | 93 | 33 | 3 | C1535926 | |
| Disease | epilepsy (implicated_via_orthology) | 7.99e-04 | 163 | 33 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | Lymphoma | 9.21e-04 | 40 | 33 | 2 | C0024299 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 9.21e-04 | 40 | 33 | 2 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | Colorectal Carcinoma | 1.03e-03 | 702 | 33 | 5 | C0009402 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.34e-03 | 195 | 33 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.38e-03 | 49 | 33 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.50e-03 | 447 | 33 | 4 | C3714756 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 1.86e-03 | 57 | 33 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | migraine disorder, type 2 diabetes mellitus | 2.06e-03 | 60 | 33 | 2 | MONDO_0005148, MONDO_0005277 | |
| Disease | Cleft Palate | 3.72e-03 | 81 | 33 | 2 | C0008925 | |
| Disease | Prostatic Neoplasms | 4.76e-03 | 616 | 33 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.76e-03 | 616 | 33 | 4 | C0376358 | |
| Disease | Adenoid Cystic Carcinoma | 5.61e-03 | 100 | 33 | 2 | C0010606 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 5.72e-03 | 101 | 33 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | prostate cancer (is_implicated_in) | 7.60e-03 | 117 | 33 | 2 | DOID:10283 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSAVDDRDSDYRSET | 191 | Q9UPW8 | |
| RSSYDDRSSDRRVYD | 56 | P49760 | |
| RGRNYTEESASEDSE | 1241 | Q9UIG0 | |
| SRDRYREEDTSEVND | 366 | Q3KP44 | |
| DRESKSSDDVDYRGS | 2706 | Q8TDJ6 | |
| DEEDYDNDKRSSRRQ | 221 | O14646 | |
| DDERRESATADAGYA | 681 | P98175 | |
| ELSSSRDRYNSDNDR | 676 | Q96T37 | |
| DTSDDNYGERSEAKR | 901 | P49796 | |
| ADNRSLDDRSRYSAG | 201 | Q8TAE7 | |
| STEAEDRSYDKLNRD | 2751 | Q01484 | |
| ERARIYSSDSDEGSE | 601 | Q8WVC0 | |
| ERAASTSARNYEREV | 86 | Q9Y6D9 | |
| RADFSDNESARLATD | 26 | Q86UY5 | |
| DSDYKRSSDDRRGDR | 36 | P52756 | |
| DYDSPERERERRNSD | 56 | P52756 | |
| DDRDSRAYESRSQDA | 211 | Q9GZU2 | |
| QRREAYNDSSDEESS | 386 | O60884 | |
| DTRRYRTSGSDEEQE | 1236 | Q8NF50 | |
| RRDSASYRDRSETDR | 596 | Q92841 | |
| AAYRDRDSQRDLVEA | 2116 | P49327 | |
| DYQRELEEARASRDE | 1656 | P35580 | |
| PRSRSRDDLYDQDDS | 526 | Q86X29 | |
| YESANGRSEDRRSSE | 371 | Q9Y383 | |
| RYDRRDDRSWSSRDD | 301 | P23588 | |
| DDRSWSSRDDYSRDD | 306 | P23588 | |
| SSRDDYSRDDYRRDD | 311 | P23588 | |
| DRESRYEEEEEQSRS | 1001 | Q9Y5B9 | |
| SDTDSDRREDDRSQH | 341 | Q99442 | |
| FSYSEAERESNRAAR | 91 | Q5K4L6 | |
| RDAERRYTSSSADSE | 16 | Q6N022 | |
| SDDDDDNDRTNRRES | 336 | Q9GZR1 | |
| DSAVDDRDSDYRSET | 181 | O14795 | |
| TDNRARESSDSEEEY | 451 | Q9BYW2 | |
| DDRDSRAYESRSQDA | 86 | Q9NZV7 | |
| REEREYEQDQSSSRD | 431 | Q5T200 | |
| YEQDQSSSRDHRDDR | 436 | Q5T200 |